Compare SGC & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGC | ACB |
|---|---|---|
| Founded | 1920 | 2013 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Apparel | Pharmaceuticals and Biotechnology |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 214.8M | 232.3M |
| IPO Year | 1994 | 2016 |
| Metric | SGC | ACB |
|---|---|---|
| Price | $13.61 | $5.20 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 4 |
| Target Price | ★ $18.00 | $4.26 |
| AVG Volume (30 Days) | 22.6K | ★ 1.3M |
| Earning Date | 11-09-2026 | 11-12-2026 |
| Dividend Yield | ★ 3.98% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | ★ $566,184,000.00 | N/A |
| Revenue This Year | $3.02 | N/A |
| Revenue Next Year | $3.83 | $9.38 |
| P/E Ratio | $100.57 | ★ N/A |
| Revenue Growth | ★ 0.09 | N/A |
| 52 Week Low | $8.30 | $2.56 |
| 52 Week High | $14.59 | $6.36 |
| Indicator | SGC | ACB |
|---|---|---|
| Relative Strength Index (RSI) | 64.98 | 78.30 |
| Support Level | $11.52 | $3.78 |
| Resistance Level | $14.57 | N/A |
| Average True Range (ATR) | 0.52 | 0.17 |
| MACD | 0.07 | 0.11 |
| Stochastic Oscillator | 100.00 | 97.89 |
Superior Group Of Companies Inc designs apparel products. The company operates through three segments: i) The Branded Products segment, under the brands BAMKO and HPI, produces and sells customized merchandising solutions, promotional products, and branded uniform programs. ii) The Healthcare Apparel segment, under the brands Wink and Fashion Seal Healthcare, manufactures and sells healthcare apparel including scrubs, lab coats, protective apparel, and patient garments. iii) The Contact Centers segment, through The Office Gurus entities, provides outsourced, nearshore, and onshore business process outsourcing (BPO), contact center, and call-center support services to customers in North America. The majority of the company's revenue is derived from the Branded Products segment.
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.